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1. Introduction 
Type 1 diabetes mellitus [T1D] results from the autoimmune destruction of insulin-
producing beta cells triggered by environmental factors (Hyoty & Taylor, 2002; Jun & Yoon, 
2003). Genetic predisposition accounts for 36-50% of disease susceptibility as demonstrated 
in monozygotic twin studies (Barnett et al., 1981; Hemminki et al., 2010; Redondo et al., 
2001). Differences in the incidence of T1D among countries are thought to be due to the 
proportions of HLA susceptibility haplotypes; however, other genes seem to be involved in 
conferring risk. On the other hand, the bulk of new T1D cases lack family history of the 
disease, altogether indicating that the contribution of exogenous factors to disease 
pathogenesis is important. Among examined environmental agents, human enteroviruses 
(HEVs) seem to play a prominent role (Hyoty & Taylor, 2002). 
HEVs are common RNA viruses spreading through the fecal-oral route. The genus comprises 
over 100 different virus types (Simmonds, 2006). The positive sense single-stranded 7.5 kb 
RNA genome contains a single open reading frame flanked by two untranslated regions 
(termed 5` and 3` UTRs). A translated single poly-protein is cleaved generating four structural 
proteins (VP1, VP2, VP3 to VP4) and seven nonstructural proteins (2A, 2B, 2C and 3A, 3B, 3C, 
3D). VP1 to VP4 proteins form the viral capsid comprising epitopes involved in virus 
neutralization; they are responsible for the type-specific protective immunity. Nonstructural 
proteins determine virus replication and cellular pathology (Agol, 2006). 
Although prediction of T1D using genetic, immunologic, and biochemical markers is rather 
accurate (Hirai et al., 2008; Notkins, 2007), the cost-benefit ratio of periodical determinations 
appears not to justify large scale screening programs. Unfortunately, primary, secondary 
and tertiary prevention strategies evaluated so far have failed to prevent or halt the 
initiation or progression of the disease. For instance, attempts to induce disease regression 
by utilizing either immunosuppressive and/or cell replacement therapies have been 
successful only temporarily (Shapiro et al., 2006; Voltarelli et al., 2007). 
A vaccine inducing neutralization of putative pathogenic HEVs may represent an ideal 
primary prevention means for T1D. Unfortunately, available data on sequence of HEV 
isolated from pancreases of patients who died at T1D onset are not sufficient to define the 
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characteristics of diabetogenic viruses. Nucleic acid technology has shown HEV genomes in 
sera, plasma or peripheral blood mononuclear cells of patients with T1D at clinical onset 
(Yeung et al., 2011). However, complete or partial virus genotyping has not been possible so 
far. Over the years, indirect evidence indicated that HEVs infections are associated with islet 
autoimmunity and the development of T1D. 
Since 1986, public health surveillance strategies have identified 3 meningitis epidemics in 
Cuba that were caused by echovirus type -4, -16, and -30. Cases of HEV infections were 
related to the appearance of autoantibodies towards pancreatic islet cells, the immunological 
hallmark of T1D. Infection-associated autoantibodies showed subtle differences among 
these epidemics in terms of titer and antigen specificity. In the epidemic of 1998, higher 
frequencies of neutralizing antibodies against echovirus 4 were found in T1D patients at 
onset as compared to controls. In the epidemic of 2006, molecular methods allowed 
detecting HEV RNA more frequently in T1D patients at onset than in non-diabetic controls. 
Finally, a case of T1D onset in strict association with a HEV infection was also reported.  
Molecular homology between beta cell antigens and HEV proteins has been suggested to 
explain the participation of HEV in T1D pathogenesis. Indeed, we have shown that 
inoculation of rabbits with selected HEV types caused the appearance of GAD65 antibodies, 
an early marker of disease progression. 
In this chapter, we provide epidemiological and experimental data indicating HEV as possible 
agents involved in islet cell associated autoimmunity and T1D. The genetic characteristics of 
the Cuban admixed population influencing T1D genetic susceptibility, the high HEV 
circulation and low T1D incidence paradox, and how the HEV-disease associations in the 
Cuban population is inserted into the worldwide landscape will be discussed. 
 
 
Fig. 1. Worldwide incidence of type 1 diabetes in children under 14 years of age. Incidence is 
given per 100,000 inhabitants per year (http://www.diabetesatlas.org/map). 
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2. Population genetic background influences T1D incidence 
The incidence of T1D varies widely across nations [Figure 1]. In the year 2009, Nordic 
countries and UK appeared to show the highest rates [>24/100,000 per year], whereas other 
European and North-American countries show high to moderate rates [8.5-24/100,000 per 
year]. Latin-America and Asia exhibit the lowest incidence [usually <8.5/100,000 per year]. 
Worldwide variations of T1D incidence appear to derive from differences in genetic and/or 
environmental factors. Within the genetic component, the proportion of 
susceptibility/protection HLA haplotypes appears to have the highest influence 
(Concannon et al., 2009). In the late ‘80s, the presence of a non-aspartic aminoacid in the 
position 57 of the DQ beta chain (Morel et al., 1988) was proposed to be the most sensitive 
marker to assess T1D risk. Then, the frequency of this marker appeared to be strongly 
related with the incidence of T1D across studied populations (Dorman et al., 1990). 
However, subsequent studies including more populations showed that the accuracy of the 
marker was not as good as expected (Dorman & Bunker, 2000).  
The peak of association between T1D and a gene has been shown to be 85 kb centromeric of 
HLA-DQB1 (Herr et al., 2000). However, the DR locus seems to confer risk to T1D per se 
(Fernando et al., 2008), not just as a result of linkage disequilibrium with DQ. In fact, effects 
of individual DR and DQ alleles on disease risk are modified by the haplotypes on which 
they are carried (She, 1996). Interestingly, a very accurate predictor of T1D susceptibility 
consists of the present of polar residues at beta 7 and beta 37 in both DR/DQ chains, 
representing an additional factor for disease progression the absence of aspartic acid at DQ 
beta 57 (Parry & Brooks, 2008). 
Not all populations display the same HLA DR/DQ as T1D susceptibility haplotypes. For 
instance, considering two-locus haplotypes, DRB1*0301-DQB1*0201 and DRB1*0401-
DQB1*0302 are positively associated with T1D in European populations, whereas DRB1*0405-
DQB1*0401 and DRB1*0901-DQB1*0303 haplotypes are associated with the disease in most 
East Asian populations (Ikegami et al., 2008). In populations of European origin, the three-
locus haplotypes DRB1*04–DQA1*0301–DQB1*0302 and DRB1*03–DQA1*0501–DQB1*0201 
have been shown to play a predominant role in conferring disease susceptibility (Fernando et 
al., 2008) being heterozygosity for both haplotypes the greatest known genetic risk for T1D. 
For the Cuban population, these haplotypes are also represented in subjects with T1D and they 
display odds ratios of 26 and 7.6, respectively (Diaz-Horta et al., 2010). On the other hand, 
DRB1*1501–DQA1*0102–DQB1*0602 is the haplotype conferring the highest protection for 
T1D in both European and Cuban populations. This is in agreement with the genetic structure 
of the Cuban population (Cintado et al., 2009) which is composed mainly by individuals with 
Spanish descent (65.05%) followed by individuals with a variable degree of Spanish and West 
African admixed ancestry (23.84%) (http://en.wikipedia.org/wiki/Cubans). In a collaborative 
study, the frequency of HLA alleles in a sample of the healthy Cuban population was analyzed 
(Alegre et al., 2007). A neighbor-joining tree using HLA-DRB1 alleles showed that the Cuban 
population is grouped together with Mediterranean populations and well separated from 
Amerindian and Oriental populations. Similarly, genetic distances (based on HLA-DRB1-
DQB1 allelic frequencies) between Cubans and other populations show that Cubans are close 
to Mediterranean and European populations. French, Berbers and Spaniards show the closest 
genetic distances to Cubans, followed by Russians, Algerians and Spanish Basques (Alegre et 
al., 2007). 
It is important to notice that associations between genotype and outcome (e.g. T1D in the 
present analysis) may be confounded by unrecognized population stratification. In Cuba, 
www.intechopen.com
 
Type 1 Diabetes – Pathogenesis, Genetics and Immunotherapy 
 
214 
population stratification exists because the population has been formed by admixture 
between subpopulations (mainly Spanish and West Africans) and admixture proportions 
(defined as the proportions of the genome that have ancestry from each subpopulation) vary 
between individuals (Hoggart et al., 2003). By utilizing ancestry informative markers, T1D–
HLA associations were controlled for factors attributable to admixture or stratification of the 
population (Diaz-Horta et al., 2010). After controlling for individual admixture, HLA allele- 
and haplotype-T1D associations mentioned above remained significant indicating their 
consistence. 
Altogether, these studies indicate that the large differences in incidence of T1D between the 
Cuban and the European population is difficult to explain on the basis of HLA alleles or 
haplotypes alone. 
The HLA region is not the sole genetic factor associated with T1D. Other genes, many of 
them involved in the regulation of the immune response (e.g., expansion of self-reactive 
cells, regulation of immune functions, interference with immune regulation) and the beta-
cell survival, contribute to disease risk (Liston, 2010). For instance, insulin has been 
suggested to be the first autoantigen to which the immune tolerance is lost (Nakayama et al., 
2005). Coincidentally, the second highest odds ratio for a genetic marker after the HLA 
region is a variable nucleotide tandem repeat (VNTR) minisatellite located at the 50 end of 
the insulin gene. More recently, a polymorphism [IFIH1] of a gene encoding for a 
cytoplasmic helicase that mediates the induction of the interferon response to viral RNA 
(Nejentsev et al., 2009) has been linked to T1D. This particular association represents genetic 
evidence suggesting the participation of RNA viruses in the etiology of T1D.  
Ethnicity has also been proposed to influence T1D incidence (Karvonen et al., 2000). Perhaps, 
one of the most illustrative examples of this phenomenon is the large difference of T1D 
incidence among the 3 principal ethnic groups living in the USA: European descendants, 
African Americans and American natives (Borchers et al., 2010). Other epidemiological study 
suggested that differences in T1D incidence among countries of Latin America could be 
explained by the proportion of the Amerindian population in those countries (Collado-Mesa et 
al., 2004). Using ancestry informative markers, we have recently shown that ancestral 
proportions do influence T1D development (Diaz-Horta et al., 2010). Studies of this type allow 
evaluating the influence of genetic background in disease incidence considering a 
homogeneous distribution of environmental factors across a given admixed population. In 
Cuba, individuals carrying high European ancestry proportions in their genome seem to be 
more prone to develop the disease than those with high African ancestry (figure 2). The size of 
this effect was estimated as 5.7 odds ratio (95% CI 1.2–36). This value embodies the odds ratio 
for T1D associated with a unit change in European admixture proportion (from 0 to 1).  
Overall, these data indicate that genetic background does influence T1D risk/protection. 
However, the involved genetic determinants are not restricted to HLA alleles or haplotypes 
alone. 
More recently, using a novel genomic analysis, it has been discovered that the genetic 
evidence linking virus infections and T1D is not limited to the IFIH1 polymorphism (Heinig 
et al., 2010). Indeed, it seems that an entire network of interferon response genes driven by 
the transcription factor IRF7 is associated with T1D. Taking in consideration that HEV 
infections are relatively frequent and that the latter genetic finding associates a robust 
antiviral response with T1D susceptibility, it is likely that the host response to certain virus 
infections is more pathogenic than the virus itself (Foxman & Iwasaki, 2011). 
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Fig. 2. Distribution of individual admixture estimates in 100 T1D cases and 129 matched 
non-diabetic subjects in a sample of the Cuban population (Diaz-Horta et al., 2010). Each of 
the three founder populations constitutes the axes of the graph. Each symbol represents a 
single subject and its position is determined by the ancestry proportions. 
3. Environmental factors and T1D incidence 
The finest epidemiological evidence indicating the large contribution of environmental 
factors in the pathogenesis of T1D is the pairwise T1D discordance of >60% among 
monozygotic twins (Knip et al., 2005; Redondo et al., 1999). Other studies of populations 
migrating to nations with dissimilar T1D incidences than that of their origins (Akerblom & 
Knip, 1998) are adequate examples, since they minimize the variability of genetic 
background. In addition, the constant and rapid increase of T1D incidence rates worldwide 
cannot be explained by changes in the genetic background of any particular populations. 
A host of variants have been associated with T1D incidence and termed “environmental 
factors”. Among them: geographic latitude, sun exposure, mean temperature, breast feeding 
rates, cow’s milk consumption, national prosperity (infant mortality rate, life expectancy at 
birth, and national human development index), urban-rural status (Borchers et al., 2010). 
These and other associations, sometimes discrepant (Borchers et al., 2010), are obviously the 
reflection of underlying molecular events. Most of these events are unknown but some has 
been extensively discussed in previous reviews (Cooke, 2009; Feillet & Bach, 2004; von 
Herrath, 2009). A variety of associations with viruses have been reported for human T1D, 
including rubella, mumps, and cytomegalovirus infections. However, among investigated 
agents, HEVs appear to play a prominent role (Hyoty & Taylor, 2002). 
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The role of the adaptive immune system in triggering or protecting against virus-induced 
autoimmunity was addressed in a pioneer study of Notkins and Yoon (Notkins & Yoon, 
1982). Two strains of encephalomyocarditis (EMC) virus were used to inoculate genetically 
susceptible mice: a diabetogenic (D) variant of the EMC virus and a non-diabetogenic (B) 
variant. Both derived from plaque purification of an M variant of the virus capable to induce 
a diabetes-like syndrome in susceptible mice. Note that EMC virus belongs to the 
picornavirus family and is classified as an animal cardiovirus. Interestingly, the two variants 
were antigenically indistinguishable but genome sequence analysis revealed 14 nucleotide 
differences between them (Bae et al., 1989). In a subsequent study, the analysis of several 
mutant viruses generated from the EMC-B and EMC-D variants, revealed that just one 
amino acid at position 776 (alanine) was responsible of the diabetogenic effects (Bae & Yoon, 
1993). Finally, it was shown that protection for T1D was achieved in an antigen-dependent 
fashion by injection of the non-diabetogenic EMC-B variant prior to the inoculation of EMC-
D diabetogenic variant. 
Although certain pathogens (e.g. putative diabetogenic HEVs) may initiate or accelerate 
autoimmunity and T1D, it is also likely that exposure to common or non diabetogenic 
pathogens may protect against this process. For example, over the last fifty years (1950 to 
2000), the decreasing incidence of prototypical infectious diseases such as hepatitis A, 
measles, mumps, rheumatic fever, tuberculosis has been linked to the increasing incidence 
of immune-mediated disorders (e.g., asthma, multiple sclerosis, Crohn’s disease) (Bach, 
2002). In addition, recognized HEV infections appear to be an infrequent event in countries 
exhibiting an elevated incidence of T1D (Viskari et al., 2005). In a study, authors measured 
the frequency of neutralizing antibodies (NtAb) against selected HEV types in pregnant 
women (mean age 25-30 years) from populations of high and low-intermediate incidence of 
T1D. The frequency of NtAb (titer ≥ 4) in the high T1D incidence country (Finland) was 40.5 
- 65.0 % (minimum - maximun) for single NtAbs against different HEVs and 38.5 % for 
multiple NtAbs. In contrast, in the adjacent regions Estonia and Karelia which are 
characterized by low T1D incidence, the values were 71.9 – 90.6 % and 84.2 %, respectively. 
Interestingly, the frequencies of NtAbs (especially those against CA9, CB4 and CB5) in 
pregnant women from Estonia and Karelia (85.7, 71.9 and 90.6 %, respectively) are similar to 
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  Mean %( M) CA9 CB1 CB2 CB3 CB4 CB5 CB6 E4 E6 E9 E11 
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57 8.3 56.1 78.9 57.9 64.9 77.2 82.5 21.1 1.8 1.8 57.9 54.4 54.4 
T
1D
 
o
n
se
t 
33 10.7 45.5 93.9 57.6 72.2 60.6 93.9 33.3 6.1 21.2 * 66.7 72.7 57.6 
Table 1. Frequency of HEV neutralizing antibodies in Cuban subjects at the clinical onset of 
T1D and nondiabetic subjects matched for age, sex, date of collection and location (Diaz-
Horta et al., 2001). * p<0.05, Fisher’s exact test. 
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those found in 7-11 year-old nondiabetic children from Cuba (78.9, 82.5 and 21.1 %, 
respectively) (Diaz-Horta et al., 2001). These data indicate that the circulation of 
enteroviruses is very high in both regions. It is also well known that the frequency of NtAbs 
against HEVs largely depends on the age of subjects, being much higher at older ages. This 
supports the hypothesis that the more a population is exposed to common HEV types the 
higher is its protection against subsequent exposure to diabetogenic HEVs. 
In animal models of spontaneous T1D (i.e., the NOD mouse and the BB rat) it has been 
demonstrated that the incidence of the disease is much higher in those animals bred in 
specific pathogen-free environments than in conventional conditions (Bach, 2002). By just 
decontaminating the food in the latter conditions an increase in incidence was observed. 
More interesting, prevention of T1D in NOD mice has been achieved by treatment with a 
variety of immune enhancers, including complete Freund's adjuvant (McInerney et al., 
1991), immunogenic but not tolerated peptides (Vaysburd et al., 1995), Mycobacterium 
avium (Martins & Aguas, 1996), Lactobacillus casei (Matsuzaki et al., 1997), Mycobacterium 
leprae (Nomaguchi et al., 2002), lymphocytic choriomeningitis virus (LCMV) (Christen et al., 
2004). T1D prevention has also been achieved by exposure to helminthes or products from 
these organisms, however, it is important to recognize that not all infecting agents, parasites 
or their products are able to induce this effect (Cooke, 2009). Another important observation 
is the fact that the timing of exposure to these “protective” agents largely influences the 
outcome (Cooke, 2009). For example, if the exposure is performed before the appearance of 
the mononuclear infiltrate in the pancreas of NOD mice (generally around week 5) then 
protection is generally achieved. After that time, exposure to the protective agent is useless 
and fails to prevent T1D. 
Thus, protection through infection or by stimulation of the immune system has allowed 
applying the term “hygiene hypothesis” to experiments in animals. The term was originally 
coined on the basis of epidemiologic studies of poliomyelitis. Several mechanisms have been 
proposed to explain this phenomenon. For example, a study conducted by von Herrath (von 
Herrath, 2009) clearly demonstrated that regulatory T-cells (CD4+ CD25+ Tregs) can 
invigorate by infection in a toll like receptor (TLR)-2 dependent fashion. These cells, instead 
of exerting effector functions such as killing infected cells or inducing interferon production, 
can turn off immune responses. The increment in TGF-ǃ concentrations induced by the viral 
infection is associated with Treg invigoration (Aumeunier et al., 2010; von Herrath, 2009). 
Other cytokines induced simultaneously are the programmed cell death ligand 1 (PD-1L) 
and the tumor necrosis factor (TNF)-ǂ which in turn may mediate the bystander death of 
auto-aggressive T-cells. The  protective effect of viral infections and other immune 
modulators has also been associated with the induction of interferon gamma-induced 
protein 10 kDa (IP-10) and other pro-inflammatory cytokines (Christen et al., 2004). 
Taken together, these data suggest that not only the adaptive immune response provides 
protection against exposure to diabetogenic viruses, but also the innate immune system. 
Multiple non-specific stimuli acting on the immune system during early childhood and 
before puberty are hoped to provide an effective strategy to reduce the increasing incidence 
of T1D (Petrovsky, 2010). 
4. Classification of enteroviruses and properties of the echovirus group 
HEVs are extremely common RNA viruses that spread mainly through the fecal-oral route. 
They are etiological agents of different clinical entities varying from asymptomatic to mild, 
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severe, or fatal diseases. Overall, these agents cause millions new infections per year in the 
US (Khetsuriani et al., 2006). The enterovirus genus comprises over 100 antigenically 
different virus types (Simmonds, 2006). The single-stranded 7.5 kb RNA genome (figure 3) is 
positive sense and contains a single open reading frame flanked by two untranslated regions 
(5` and 3` UTRs). The coding region is translated into a single polyprotein (of approximately 
2,200 amino acids) which is cleaved to generate four structural proteins (VP1 to VP4) and 
seven nonstructural proteins (2A to 2C and 3A to 3D). VP1-VP4 proteins are assembled to 
form the viral capsid whose external surface comprises the epitopes involved in virus 
neutralization that are responsible for the type-specific protective immunity. Nonstructural 
proteins have enzymatic functions and play essential roles in virus replication and cellular 
pathology. An important property of HEVs (common to all RNA viruses) is their high 
mutation and recombination rates. RNA replication is extremely error-prone, due to the lack 
of proofreading activity of the viral RNA-dependent RNA polymerase, taking the error rate 
to approximately one per genome replication (Savolainen-Kopra & Blomqvist, 2010).  
 
 
Fig. 3. HEV genome organization. 
HEVs were originally classified on the basis of shared pathogenic properties in experimental 
animals. For example, polioviruses were described to cause a poliomyelitis resembling 
disease in primates; coxsackieviruses A and B, produced flaccid and spastic paralysis in 
newborn mice, respectively; echoviruses were not associated to any known clinical 
symptom or disease. Echoviruses received their name from the initials of “Enteric isolates”, 
“Cytopathogenic in tissue culture”, isolated from “Humans” and, “Orphans” because they 
were not apparently associated to any disease (Fields et al., 2007). Currently, many HEV 
types have been fully sequenced allowing their genetic classification. For example, 
considering the amino acid similarity of the capsid protein region P1 (comprising VP4, VP2, 
VP3 and VP1 proteins) HEVs are now grouped into species A, B, C and D (table 2).  
As observed in table 2, there is some conflict between the classical subgroup division and 
the genetic classification of HEVs. For instance, although coxsakieviruses B, echoviruses 
(now within the species B) and polioviruses (species C) are rather genetically homogeneous, 
coxsackieviruses A distribute in species A, B and C. On the other hand, echoviruses took 
their name because they were not originally associated to any disease. Now, however, it is 
known that they are one of the main causes of aseptic meningitis as well as other diseases, 
and that these agents are widespread in the environment (Djikeng et al., 2009). Interestingly, 
the genetic subgrouping of enteroviruses is quite consistent regardless the zone of the 
genome being used for the analysis (Hyypia et al., 1997).  
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Species Number of 
known 
serotypes 
Serotypes 
A 17 coxsackievirus A2 (CV-A2), CV-A3, CV-A4, CV-A5, CV-A6, 
CV-A7, CV-A8, CV-A10, CV-A12, CV-A14, CV-A16, 
enterovirus A71 (EV-A71), EV-A76, EV-A89, EV-A90, EV-A91, 
EV-114 
B 58 coxsackievirus B1 (CV-B1), CV-B2, CV-B3, CV-B4, CV-B5, CV-
B6, CV-A9, echovirus 1 (E-1), E-2, E-3, E-4, E-5, E-6, E-7, E-9, 
E-11, E-12, E-13, E-14, E-15, E-16, E-17, E-18, E-19, E-20, E-21, 
E-24, E-25, E-26, E-27, E-29, E-30, E-31, E-32, E-33, enterovirus 
B69 (EV-B69), EV-B73, EV-B74, EV-B75, EV-B77, EV-B78, EV-
B79, EV-B80, EV-B81, EV-B82, EV-B83, EV-B84, EV-B85, EV-
B86, EV-B87, EV-B88, EV-B93, EV-B97, EV-B98, EV-B100, EV-
B101, EV-B106, EV-B107 
C 20 poliovirus (PV) 1, PV-2, PV-3, coxsackievirus A1 (CV-A1), 
CV-A11, CV-A13, CV-A17, CV-A19, CV-A20, CV-A21, CV-
A22, CV-A24, enterovirus C95 (EV-C95), EV-C96, EV-C99, 
EV-C102, EV-C104, EV-C105, EV-C109 and EV-C113. 
D 4 EV-D68, EV-D70, EV-D94 and EV-D111 
Table 2. Classification of human enteroviruses (Adapted from the Picornaviridae database 
http://www.picornaviridae.com/; Mars 2011). 
 
 
 YEAR OF THE EPIDEMIC 
 1986 2000  2001 
 (Uriarte et al., 
1987) 
(Cabrera-Rode 
et al., 2003; 
Sarmiento et 
al., 2001) 
(Cabrera-
Rode et al., 
2005) 
Echovirus serotype 4 16 30 
Number of separate isolates obtained 14 47 43 
Number of reported aseptic meningitis 
cases 
~300,000 16,943 14,477 
No. ICA-positive/No. echovirus-
infected children 
17/48 35/38 7/8 
No. GADA-positive/No. echovirus-
infected children 
ND 11/38 0/8 
No. IA2A-positive/No. echovirus-
infected children 
ND 0/38 0/8 
No. IA-positive/No. echovirus-infected 
children 
ND 17/38 0/8 
Table 3. Summary of epidemiology and islet associated autoantibodies in echovirus 
epidemics in Cuba. ND= not done 
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5. Cuban epidemics of aseptic meningitis due to echoviruses 
Since 1986, virus surveillance in Cuba has identified 3 different echoviruses (HEVs B) as the 
causing agents of 3 epidemics of aseptic meningitis (table 3). The predominant clinical 
manifestations in all three epidemics were vomiting, headache, and fever. No deaths related 
to aseptic meningitis were reported and all patients recovered completely. Cerebrospinal 
fluid (CSF), sera (during acute and convalescent stages of the disease) and feces were 
utilized for enterovirus detection using a specific RT-PCR technique. For enterovirus 
identification a neutralization test using the Lim–Benyesh–Melnick (LBM) antisera pools 
was used. Viral isolation was achieved by inoculating specimens on monolayers of human 
embryo fibroblasts (PhuE-1) and monkey kidney cells (Vero). Sera from infected children 
were matched with at least two control sera from healthy children for age, sex, date of 
collection, and location. All control subjects had no family history of diabetes, were screened 
for diabetes-associated antibodies (ICA, GADA, IAA, IA2A) and for neutralizing antibodies 
against different enterovirus serotypes.  
The presence of islet cell antibodies (ICA) is considered the immunological hallmark of T1D. 
One of the most notable observations from these HEV epidemics is that in the convalescent 
but not in the acute stage of the infection, ICA seroconversion was demonstrated. On the 
other hand, in the epidemic caused by echovirus 16 we also detected the emergence of IAA, 
GADA and IA2A (Cabrera-Rode et al., 2003). The islet cell autoimmunity was clearly 
infection-associated, since no serum samples from uninfected subjects serologically negative 
for neutralizing antibodies to E16 and E30 had ICA. The seroconversion of T1D islet 
associated antibodies in subjects does not seem to be a general unspecific antibody response, 
since all infected subjects were negative for thyroid microsomal or parietal gastric cell 
autoantibodies. As for the echovirus 30 meningitis, we detected ICA seroconversion in a 
high percentage of patients but not GADA, IAA or IA2A seroconversion. From this and 
other studies (table 4), it can be observed that different echovirus types are associated with a 
variety pancreatic autoantibodies. 
 
ICA GADA IA2A IAA Serotype Reference 
 
- - Echovirus 3 (Williams et al., 2006) 
 
- Echovirus 6 (Otonkoski et al., 2000) 
 
- - Echovirus 9 (Vreugdenhil et al., 2000) 
 
Echovirus 16 (Cabrera-Rode et al., 2003) 
 
- - - Echovirus 30 (Cabrera-Rode et al., 2005) 
 
- - Non polio HEV (Lonnrot et al., 2000b) 
 
- Non polio HEV (Hyoty & Taylor, 2002) 
Table 4. Patterns of T1D-associated autoantibodies in the course of echovirus infections. 
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During the echovirus 30 epidemic we reported an adolescent who developed pancreatic 
autoantibodies and T1D after infection (Cabrera-Rode et al., 2005). ICA and IA2A were 
detected post-infection and; the analysis of neutralizing antibodies to enterovirus serotypes 
most frequently isolated during the last 30 years in Cuba showed high titers of neutralizing 
antibodies only for E30 (titer 1:80) suggesting that this virus was the agent causing the 
aseptic meningitis. Interestingly, the patient carried the HLA DR15/DR7 and DQ2/DQ6 
determinants that confer T1D protection. 
It is important to notice that in mice inoculated with the echovirus 4 strain circulating 
during the late ‘80s in Cuba there was a reduction of the insulin concentration and overall 
protein synthesis in pancreatic islets (Szopa et al., 1992). Remarkably, Roivainen et al 
(Roivainen et al., 2002) showed that the capacity of an enterovirus to kill human beta cells or 
impair their function is not entirely defined by the serotype. For example, the prototype 
echovirus 30 strain (Bastianni) appear not to produce damage to beta cells while other 
isolates of echovirus 30 do. Similar results were obtained with echovirus 9 (Roivainen et al., 
2002). Another interesting observation from echovirus epidemics in Cuba is that the titer of 
islet-associated autoantibodies correlates with the titer of neutralizing antibodies against 
echoviruses. This suggests that the extent of infection and the antiviral immune response 
could influence the intensity of the humoral response against host antigens (Figure 4). 
 
 
Fig. 4. Correlation between echovirus 16 neutralizing antibodies and ICA titers in sera of 
patients with aseptic meningitis in the acute (A) and convalescent (B) phase. 
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We also evaluated the induction of T1D associated antibodies by HEVs in experimental 
animals. In particular, rabbits were used since HEVs do not replicate in their cells (Fields et 
al., 2007). This minimizes the possibility of generating of humoral responses as consequence 
of beta-cell damage and subsequent autoantigen release. Strikingly, seroconversion to 
GAD65 antibodies was restricted to HEVs of the B species. Antibodies recognizing GAD65 
were absent after inoculation with HEVs of the A and the C species (Sarmiento et al., 2007b). 
Antibodies against IA2 or insulin were undetected. Although indirect, this evidence 
suggests that different HEVs of the species B could share epitopes with GAD65. Thus, 
molecular mimicry might explain the induction of T1D/associated autoantibodies during 
HEV epidemics. 
Taken together, these results show the association between echovirus epidemics and the 
induction of T1D associated autoantibodies. Other studies have shown similar results (Frisk 
& Tuvemo, 2004; Hiltunen et al., 1997; Lonnrot et al., 2000a; Moya-Suri et al., 2005; 
Oikarinen et al., 2011; Sadeharju et al., 2001; Salminen et al., 2003; Williams et al., 2006). 
Diabetogeneicity seems to be associated to HEVs of the B species although it is not restricted 
to one particular serotype or strain. 
6. Detection of HEVs at T1D onset and in prediabetic stages 
In 1999, neutralizing antibodies (NtAb) against different HEV types were measured in 
subjects with T1D at diagnosis and in controls matched for location, time of sampling, and 
age (Diaz-Horta et al., 2001). Both, patients and control subjects showed a high frequency of 
antibodies against a variety of HEV types (Table 1). Strikingly, the sole HEV serotype with 
NtAbs at higher frequency in cases vs. controls was echovirus 4, i.e., the same serotype that 
caused the huge epidemic of aseptic meningitis during the year 1987. More recently, HEV 
RNA was searched for in blood of T1D children at the time of diagnosis, in their first degree 
relatives with or without ICA and in matched non diabetic controls (Sarmiento et al., 2007a). 
As shown in table 5, subjects at diagnosis and subjects with ICA showed higher frequencies 
of HEV RNA than their matched controls. These and other results (Andreoletti et al., 1997; 
Clements et al., 1995; Craig et al., 2003; Moya-Suri et al., 2005; Nairn et al., 1999; Yin et al., 
2002) strongly suggest the link between HEV detection and the early stages of T1D.  
 
GROUP N HEV RNA+ (%) P VALUE 
T1D at clinical onset 
Matched controls 
34 
68 
9 (26,5) 
2 (2,9) 
0,0007 
First degree relatives of T1D patients (ICA+) 
Matched controls 
32 
64 
5 (15,6) 
0 (0,0) 
0,0033 
First degree relatives of T1D patients (ICA-) 
Matched controls 
62 
62 
1 (1,6) 
1 (1,6) 
NS 
First degree relatives of T1D patients (ICA+) 
First degree relatives of T1D patients (ICA-) 
32 
62 
5 (15,6) 
1 (1,6) 
0,0164 
Table 5. Frequency of enterovirus RNA in blood of subjects with T1D at clinical onset, their 
first degree relatives and controls matched for age, sex, date of collection and location 
(Sarmiento et al., 2007a). 1. p values were generated by the Fisher’s exact test. NS = not 
significant.  
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The frequency of HEV genome positivity appeared to vary according to the specimen 
(Schulte et al., 2010a). In newly diagnosed T1D patients, the highest frequency of HEV RNA 
is detected in peripheral blood mononuclear cells (PBMC) followed by plasma or serum. 
Cerebrospinal fluid (CSF) and stool samples are the specimens with the lowest percent of 
HEV genome detection. Since HEVs primarily replicated in the gut, a recent study 
addressed the question of whether these agents could be detected in the small intestine of 
patients at clinical onset of T1D (Oikarinen et al., 2008). By in situ hybridization or 
immunohistochemistry, up to 50% of T1D patients were positive for HEVs. This finding is 
apparently in contrast with studies on feces (Schulte et al., 2010a)(and unpublished results). 
It is however known that enterovirus isolation from feces is difficult when virus titer is low. 
This finding suggests that an asymptomatic/low level infection takes place in children 
during the initial stages of the disease. In this regard, it should be pointed out that the 
amount of HEV genomes in serum/plasma and blood cells is extremely low and can only be 
evidence with highly sensitive methods  (Sarmiento et al., 2007a; Schulte et al., 2010a). These 
findings indicate that small amounts of HEVs may derive from infected cells, e.g., cells of 
the islets of Langerhans islets or cell-debris (Schulte et al., 2010a; Schulte et al., 2010b). 
Though not yet demonstrated, virus low level persistence and/or low virus clearance are 
involved in T1D pathogenesis. In a recent study (Feuer et al., 2009), intracranial inoculation 
of BALB/c pups with Coxsackie B3 resulted in detection of the infecting virus at least for 10 
days. At day 30, infectious virus was no longer present though viral RNA could be 
demonstrated by sensitive RT-PCR methods. Similar results have been reported for other 
target tissues, such as the myocardium (Kim et al., 2001; Klingel et al., 1992; Reetoo et al., 
2000).  
A recent meta-analysis by Craig and colleagues (Yeung et al., 2011) strongly indicates that 
HEVs (in terms of RNA detection) are unequivocally associated with T1D at the time of 
clinical presentation or at preclinical stages. Other data corroborate this association. Among 
them, the high frequency of IgM/IgG antibodies against HEVs (Banatvala et al., 1985; 
Elfaitouri et al., 2007; Helfand et al., 1995; King et al., 1983), the presence of interferon-ǂ or 
dsRNA-dependent protein kinase R (indirect markers of virus infection) in serum and 
pancreas (Chehadeh et al., 2000; Foulis et al., 1987; Huang et al., 1995; Richardson et al., 
2009), the demonstration of HEV capsid proteins in pancreatic islets (Dotta et al., 2007; 
Richardson et al., 2009; Tanaka et al., 2009). 
7. Conclusion 
The genetic background of a population influences the incidence of T1D. Although the HLA 
region confers the highest odds ratio, several other genes contribute to T1D susceptibility as 
suggested in our admixture study. The link between the IFIH1 polymorphism, and more 
recently the discovery of an entire network of interferon response genes driven by IRF7, 
corroborate the hypothesis that viruses have a role in T1D pathogenesis. These studies also 
evidence that HEV circulation is inversely proportional to T1D incidence. Upon exposure to 
a diabetogenic HEV, both the innate and adaptive immune response seem to have an 
influence on whether or not an individual will progress towards organ-specific 
autoimmunity and destruction of beta cells. 
As indicated by studies of meningitis epidemics in Cuba, echoviruses - once thought to be 
harmless - appear to comprise a variety of pathogens causing slow and progressive disease. 
Current data indicate that different HEV types may be associated with the initial stages of 
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T1D. Technical improvements are however needed to unequivocally prove this hypothesis 
and to pave the way to viral vaccines as a preventing measure against T1D. 
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